kabutan

Kohjin Bio, Ordinary Profit Forecast for the Fiscal Year Revised Downward to an Unexpected 56% Decrease, Dividend Revised down by 15 Yen

Fri Feb 13, 2026 3:30 pm JST Earnings

177A Kohjin Bio Co.,Ltd. 【J-GAAP】

Earnings Report

Kohjin Bio Co.,Ltd. <177A> [TSE Growth] announced its financial results after the market closed on February 13th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) dropped 48.0% from the same period last year to 0.38 billion yen.

In addition, the full-year forecast for consolidated ordinary profit has decreased 58.9%, from the previous forecast of 1.13 billion yen to 0.46 billion yen (compared to 1.06 billion yen in the previous period). This changes the outlook from an anticipated profit increase to a projection of a 56.2% decrease in profit.

Based on the full-year plan announced by the company after the downward revision, our estimate of the consolidated ordinary profit for the October to March period (second half) has decreased 77.4%, from the previous forecast of 0.86 billion yen to 0.19 billion yen (compared to 0.64 billion yen in the same period of the previous year). This changes the outlook from an anticipated profit increase to a projection of a 70.0% decrease in profit.

Due to a decline in performance, the company has significantly reduced its planned year-end lump-sum dividend for the current fiscal year from the original plan of 25 yen to 10 yen (compared to 24 yen in the previous period).

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit significantly dropped to 0.11 billion yen, a 65.1% decrease compared to the same period last year. The operating profit margin sharply declined from 20.9% in the same period last year to 10.1%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2024 3,923 675 740 516 103.0 69.5 Feb 14, 2025 J-GAAP
Apr - Dec, 2025 3,791 387 385 279 54.7 82.4 Feb 13, 2026 J-GAAP
YoY -3.4% -42.7% -48.0% -45.9% -46.9%

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2025 Prev 3,175 808 863 620 121.3 25 Nov 13, 2025 J-GAAP
Oct - Mar, 2025 New 2,467 207 195 133 26.0 10 Feb 13, 2026 J-GAAP
Revision Rate -22.3% -74.4% -77.4% -78.5% -78.5%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 5,679 1,065 1,135 822 160.8 25 May 14, 2025 J-GAAP
Mar, 2026 New 4,971 464 467 335 65.5 10 Feb 13, 2026 J-GAAP
Revision Rate -12.5% -56.4% -58.9% -59.2% -59.2%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 2,699 612 649 517 102.6 24 May 14, 2025 J-GAAP
Oct - Mar, 2025 Guidance 2,467 207 195 133 26.0 10 Feb 13, 2026 J-GAAP
YoY -8.6% -66.2% -70.0% -74.3% -74.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 4,770 596 635 384 92.4 14 May 15, 2024 J-GAAP
Mar, 2025 5,206 991 1,065 794 157.6 24 May 14, 2025 J-GAAP
Mar, 2026 Guidance 4,971 464 467 335 65.5 10 Feb 13, 2026 J-GAAP
YoY -4.5% -53.2% -56.2% -57.8% -58.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 1,416 296 324 239 47.7 20.9 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 1,283 316 325 278 55.2 24.6 May 14, 2025 J-GAAP
Apr - Jun, 2025 1,219 131 116 82 16.1 10.7 Aug 14, 2025 J-GAAP
Jul - Sep, 2025 1,285 126 156 120 23.5 9.8 Nov 13, 2025 J-GAAP
Oct - Dec, 2025 1,287 130 113 77 15.1 10.1 Feb 13, 2026 J-GAAP
YoY -9.1% -56.1% -65.1% -67.8% -68.3%

Related Articles